InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,590.40
(
-0.11%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
82.86
(
-0.74%
)
Bitcoin
64,034.95
(
1.37%
)
Post# of 514
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Investor100

Send PM Follow Ignore
Followers 505
Posts 6242
Boards Moderated 0
Alias Born 09/20/2006

Investor100

Re: None

Friday, 05/06/2016 9:30:08 AM

Friday, May 06, 2016 9:30:08 AM

Post# of 514
Jeffries states Buy (Raised to $5)

http://247wallst.com/investing/2016/05/06/top-analyst-upgrades-and-downgrades-activision-blizzard-berkshire-hathaway-fireeye-immunomedics-square-sunpower-weatherford-williams-and-yelp/

Immunomedics Inc. (NASDAQ: IMMU) was raised to Buy from Hold and the price target was raised handily to $5.00 from $1.50 at Jefferies. Wells Fargo maintained its Outperform rating with a valuation range of $3.00 to $3.50, noting that IMMU132 has emerged as a major value driver accelerating its approval potential. The stock closed down 7.5% at $3.46 on Thursday. Its 52-week range is $1.50 to $5.05.

Read more: Top Analyst Upgrades and Downgrades: Activision Blizzard, Berkshire Hathaway, FireEye, Immunomedics, Square, SunPower, Weatherford, Williams and Yelp - 24/7 Wall St. http://247wallst.com/investing/2016/05/06/top-analyst-upgrades-and-downgrades-activision-blizzard-berkshire-hathaway-fireeye-immunomedics-square-sunpower-weatherford-williams-and-yelp/#ixzz47skcCoUX
Follow us: @247wallst on Twitter | 247wallst on Facebook
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up